NEW YORK, March 29, 2017 /PRNewswire/ --
FinancialBuzz.com News Commentary
Data published in a researchreport by Grand View Research, Inc., projects that the global medical cannabis market will reach a value of USD 55.8 billion by 2025. The projection takes into consideration the continuous successful legalization campaigns
The research indicates that there is an increasing interest amongst academic researchers and healthcare providers regarding the therapeutic potential of cannabis products. Some of the potential therapeutic values are suppression of vomiting & nausea, pain relief and appetite stimulation. In addition, cannabis is effective in providing relief to the patient suffering from HIV/AIDS, glaucoma, cancer and multiple sclerosis. In the year 2015, chronic pain was the largest application segment in this market.
CURE Pharmaceutical Holding Corp. (OTCQB: CURR) is a drug delivery technology company serving the pharmaceutical, biotech, veterinarian, medical foods markets, cannabinoid molecules and new chemical entities (NCEs).
Earlier today, CURE Pharmaceutical Holding Corp. announced a distribution and license agreement with Long Beach, Calif-based, Redbarn Pet Products, LLC ("Redbarn"), for the development of various oral thin film veterinary products. The demand for US animal health products is more than $12 billion per year.
"This agreement is important for CURE as it marks the first distribution and licensing agreement we have executed since we received our method of use for animal products. We are grateful and excited to be working with such a high quality partner and look forward to a long-standing relationship with Redbarn," said Rob Davidson, CEO of CURE Pharmaceutical. "Further, it demonstrates the versatility of our CureFilm™ technology, allowing it to easily be applied to both human and animal consumption, as well as both OTC and Rx formulation. We anticipate multiple additional deals to be announced in the short term, and look forward to sharing these milestones with our stockholders."
As part of the agreement, CURE will formulate, develop and manufacture a variety of pet products, including multi-vitamins; flea, tick, heartworm, weight control, joint care, dental, shin health, digestive health, behavioral relief, anal glad and antifungal; hip and joint; allergies, pain and anti-nausea products to be sold over-the-counter. CURE will also provide Redbarn with products for dogs and cats specifically distributed through veterinary offices, including anti-inflammatory, pain relief, itch relief, allergies, anti-nausea, blood pressure or fluid retention, epilepsy and seizure control; heart, antibiotics and steroids. All of these products will utilize the company's proprietary formulation and manufacturing capabilities and its patented CureFilm™ technology.
Earth Science Tech Inc. (OTC: ETST), an innovative biotech company focused on industrial hemp and cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices, and its two subsidiaries: Earth Science Pharmaceutical and Cannabis Therapeutics, announced the projected timeline for the delivery of its MSN-2 medical device, the negotiation of a strategic partnership with Connexions Commerciales Internationales CT Inc., and the beginning of negotiations with partners in Africa and Japan. ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality and purity of High Grade Hemp CBD Oil. ETST's primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties.
General Cannabis (OTCQB: CANN), the comprehensive resource for the highest quality service providers available to the regulated Cannabis Industry, announced today that its security division, Iron Protection Group (IPG), the premier provider of protection services for the regulated cannabis industry, will begin offering its services in California. By opening an office in Sacramento, IPG will serve the largest regulated cannabis market in the world, now that the state voted to legalize the recreational use of marijuana for adults last November. "The demand for security services in California is skyrocketing," said Hunter Garth, Managing Director of IPG. "As a known security leader in Colorado, we are now seeing a dramatic rise in security and transportation requests from companies throughout the state. By opening our first office in the state capital, we plan to fulfill a vital component of the regulated cannabis industry in this substantial market."
OWC Pharmaceutical Research Corporation (OTCQB: OWCP), through its wholly-owned subsidiary, One World Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. The company announced the highly promising results of its topical cream efficacy tests following months of study and scientific analysis. Chairman and CEO, Mr. Mordechai Bignitz, has directed OWC's scientific team to submit an operating plan within 60 to 90 days to conduct double-blind efficacy tests of our cannabinoid-based topical cream on other skin disorders and conditions. Dr. Yehuda Baruch, the Company's Chief Science Officer and Director of Research and Regulatory Affairs, commented, "As a practicing physician and a scientist who has been treating patients with cannabis for medical purposes for more than two decades, I am truly excited by our success to date and, more importantly, I am thrilled to be part of a professional scientific study on humans that should actually validate what I have believed and experienced for years - Cannabis helps treat a multitude of health conditions."
Cannabis Sativa Inc. (OTCQB: CBDS) develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses. It holds the license for a medicinal cannabis strain called NZT, a cannabis lozenge delivery methodology, and a cannabis trauma cream formula. The Company is also developing a third strain of cannabis plant named CT22. The Company also conducts its operations through its subsidiary; Wild Earth Naturals Inc. Wild Earth is an herbal skin care products formulation and marketing company that plans to target the natural healthcare products market in the United States and abroad. It offers Go Deep, Go Deep EXTRA, Face Garden, Body Garden and Lip Garden.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: Media Contact: firstname.lastname@example.org +1-877-601-1879
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All